Archive for May 23rd, 2010

Sunday, May 23rd, 2010 | Author: Vision Shopsters

“The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 – Growing Demand Drives Investment in Capacity”. The study, which is an offering from the company’s Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regions – Europe, North America and Asia Pacific. The factors that drive and restrain the growth of the HPAPIs market are also analyzed in the report. In addition, the research provides market share analysis of the leading HPAPIs producers for major regions. The market for HPAPIs is also analyzed based on the product types and therapeutic applications at a global level. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope

- HPAPIs market revenues data from 2005 to 2009 and forecast for six years to 2015.
- HPAPIs in key regions – Europe, North America and Asia Pacific.
- Coverage of the product types and therapeutic applications of the global HPAPIs market.
- Drivers such as increasing demand due to the growth in better targeted drugs and restraints such as the economic recession for the global market as well as for the regional markets.
- Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world such as Sigma Aldrich, Bristol Myers Squibb, Sanofi Aventis, Carbogen Amcis and Novasep.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the global HPAPIs market.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the HPAPIs market.
- Identify macro and micro-economic trends shaping and driving the global HPAPIs market.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1964/The-Future-of-High-Potency-Active-Pharmaceutical-Ingredients-HPAPIs-Market-Forecasts-and-Growth-Opportunities-to-2015-Growing-Demand-Drives-Investment-in-Capacity.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

“The Future of the Home Healthcare Equipment Market to 2016 – Increasing Awareness Driving Demand” provides key data, information and analysis on the global home healthcare equipment market. The report provides market landscape, competitive landscape and market trends information on seven home healthcare equipment market segments – glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for seven home healthcare equipment market categories – glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the home healthcare equipment market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the home healthcare equipment market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the home healthcare equipment market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global home healthcare equipment market and the factors shaping it.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1955/The-Future-of-the-Home-Healthcare-Equipment-Market-to-2016-Market-Forecasts-Competitive-Landscape-and-Pipeline-Analysis.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

“The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 – Better and More Cost-Effective Treatment Options Create Opportunities”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global blood disorders market. The report analyzes the markets for blood disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets

Scope

The scope of this report includes:
- Annualized market data for the blood disorders market from 2001 to 2009, forecast forward to 2016
- Analysis of the leading therapeutic segments including anemia, thrombosis, hemophilia, neutropenia and thrombocytopenia
- Analysis of the blood disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the blood disorders market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are Amgen, Inc., Sanofi-Aventis, Bristol-Myers Squibb, Centocor Ortho Biotech Inc., and Baxter.
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global blood disorders market

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Companies Mentioned

Amgen
Sanofi-Aventis
Bristol-Myers Squibb
Centocor Ortho Biotech Inc
Baxter

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1963/The-Future-of-Blood-Disorders-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Better-and-More-Cost-Effective-Treatment-Options-Create-Opportunities.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

“The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 – Increasing Prescription Rate to Drive Revenues”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns and sales are forecast until 2016 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:
- Annualized market data for the dermatology therapeutics market from 2001 to 2009, forecast forward to 2016
- Analysis of the leading therapeutic segments. These include Acne, Psoriasis, Dermatitis, Rosacea and Skin diseases.
- Analysis of the dermatology therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the dermatology therapeutics market including market size, annual cost of therapy, and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, GlaxoSmithKline, Leo Pharma, Sanofi-Aventis, Genentech, Novartis AG, Johnson & Johnson, Galderma Pharma SA, and Merck & Co, Inc.
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global dermatology therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Companies Mentioned

GlaxoSmithKline plc (GSK)
Johnson & Johnson
Bayer AG
Merck & Co., Inc
Novartis AG
Sanofi-Aventis
LEO Pharma A/S
F. Hoffmann-La Roche Ltd
L’Oreal
Galderma S.A
Nestle S.A.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1962/The-Future-of-Dermatology-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Increasing-Prescription-Rate-to-Drive-Revenues.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

“The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 – Increasing Generic Competition Creates Challenges”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:
- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.
- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in the various phases of drug development.
- Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.
- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Companies Mentioned

Pfizer, Inc.
Eli Lilly and Company
Johnson & Johnson
Endo Pharmaceuticals
Novartis AG
Merck & Co Inc
Cephalon, Inc.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1961/The-Future-of-Pain-Management-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Increasing-Generic-Competition-Creates-Challenges.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

“The Future of Ophthalmic Devices, Market Forecasts and Growth Opportunities to 2016 – The Vision Care Segment Emerges as a Key Revenue Generator” provides key data, information and analysis on the global ophthalmic devices market. The report provides market landscape, competitive landscape and market trends information on four ophthalmic devices market categories – cataract surgery devices, refractive surgery devices, vision care, and ophthalmic diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for four ophthalmic devices market categories – cataract surgery devices, refractive surgery devices, vision care, and ophthalmic diagnostic equipment.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the ophthalmic devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Essilor, Johnson & Johnson Vision Care, HOYA, CIBA Vision, Bausch & Lomb, Carl Zeiss, Alcon, Cooper Vision, and Abbott Medical Optics (AMO).

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the ophthalmic devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the ophthalmic devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global ophthalmic devices market and the factors shaping it.

Companies Mentioned

Essilor International
Johnson & Johnson Vision Care
CIBA Vision Corporation
Bausch & Lomb
Carl Zeiss
Alcon
Abbott Medical Optics
Hoya Corporation

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2145/The-Future-of-Ophthalmic-Devices-Market-Forecasts-and-Growth-Opportunities-to-2016-The-Vision-Care-Segment-Emerges-as-a-Key-Revenue-Generator.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

The report provides key information and analysis on the market opportunities in the clean technology industry. The report covers key market trends and growth forecasts for the wide range of clean technology industries that include energy generation, energy storage, energy infrastructure, energy efficiency, air, water, manufacturing/industrial, transportation, recycling & waste management, material management and agriculture. Deal landscape covers the deal analysis for each of the clean technology industry from 2005 to 2009. It also provides the analysis on the basis of geography and deal type for the year 2009. Global warming concerns and government legislations are constantly promoting the clean technology industries across globe. These advancements are expected to cause a significant growth in the demand for clean technologies in various industries.

Scope

- Market definition and the factors driving the clean technology industry.
- The report covers the market size and forecasts for the wide spectrum of clean technology industries that include energy generation, energy storage, energy infrastructure, energy efficiency, air, water, manufacturing/industrial, transportation, recycling and waste management, material management and agriculture.
- Annualized market revenues data from 2005 to 2009, forecast for 11 years to 2020.
- Investment landscape of the overall clean technology industry on the basis of geography and investment type in 2009
- Investment breakdown for each of the clean technology industries by geography and investment type for 2009

Reasons to buy

- Exploit growth opportunities in the wide range of clean technology industries.
- Develop business strategies by understanding the trends and developments that are driving the clean technology industry across globe.
- Devise market-entry and expansion strategies among the various clean technologies.
- What is the future demand potential of the clean technologies in various industries? – Identify, understand and capitalize.
- Make informed business decisions from the insightful and in-depth deal analysis for the various clean technology industries.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2144/The-Future-of-Clean-Technology-Markets-to-2020-Market-Forecasts-Deal-Analysis-and-Investment-Opportunities.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

Summary

New report “The Future of the Oil Fields Services Industry to 2015 – Rebound in Exploration and Drilling Activity Drives Growth” provides an in-depth analysis of the global oil field services industry and highlights the various concerns, shifting trends and major regions in the global oilfield services industry. The report provides forecasts of the global oilfield services industry to 2015. The report also provides segmental forecasts of the global exploration and evaluation services market, global drilling services market and global completion and production services market. The report provides in-depth analysis of the key trends and challenges in the global oilfield services industry. The report also provides an analysis of the geographical trends in each of the market segments. An analysis of the competitive scenario and market share analysis is also provided for each of the market segments. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Provides a complete overview of the future prospects of the global oil field services industry.
- Analyzes the oil field services industry in the major regions of the world. Regions covered include North America, South and Central America, Europe, Middle East and Africa and Asia Pacific
- Analyzes each of the market segments including exploration and evaluation services, drilling services and completion and production services from 2005 to 2015.
- Identifies the high growth areas and markets for the future business expansion and market expansion.
- Analyzes the competitive scenario providing a market share analysis of the key competitors in the industry for 2009. Key companies covered Schlumberger, Petroleum Geo Services (PGS), Fugro, TGS, Geokinetics, Dawson geophysical company, Tidelands Geophysical Company, ION Geophysical Corporation, BGP (CNPC), Global Geophysical, Geotrace Technologies, China Oilfield Services (CNOOC), and Polarcus
- Analysis of the key drivers and restraints, with review of the various concerns, shifting trends and major regions in the global oil field services industry. Trends are also provided at a regional and segment level.

Reasons to buy

- Develop business strategies with the help of specific insights about the global oil field services industry.
- Identify opportunities and challenges in the global oilfield services industry.
- Understand the market positioning of the oilfield service providers.
- Increase future revenues and profitability with the help of insights on the future opportunities and critical success factors in the global oil field services industry.
- Benchmark your operations and strategies against the major players in the global oilfield services industry.

Companies Mentioned

BJ Services (Baker Hughes)
China Oil Field Services Ltd
National Oilwell Varco (Varco)

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2992/The-Future-of-the-Oil-Fields-Services-Industry-to-2015-Rebound-in-Exploration-and-Drilling-Activity-Drives-Growth.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

Summary

“South American Renewable Energy Markets to 2020 – Favorable Policies and Regulations to Drive Growth in The Region”, which provides key data, information and analysis on the South American renewable energy market. The report provides market drivers, restraints and market trends information for the top five countries in the South American region. The report also analyses the four major renewable energy technologies, namely small hydro, wind, solar and biomass in each of the top five countries in the region. The report provides comprehensive information on the key market trends with superior analytics. It also reviews the policies and regulatory framework of the renewable energy market. The South American renewable energy market is expected to increase at a Compound Annual Growth Rate (CAGR) of 10.1% over the forecast period 2009–2020. Small hydro and wind energy are likely to experience high growth during this period. The cumulative installed capacity of small hydro power in the top five countries is expected to increase at a CAGR of 7.8% during the period. The major drivers for the growth in the South American renewable energy market include favorable polices, legislation in respective countries, financial support from international banks and clean development mechanism projects. The key restraints include the lack of incentives and the lack of a binding agreement at the Copenhagen summit.

Scope

- Key geographies such as Brazil, Argentina, Colombia, Venezuela and Chile.
- Cumulative Installed Capacities for renewable energy technologies globally from 2000 to 2009 and forecast up to 2020.
- Percentage share of the top 10 countries in wind, solar and biomass globally from 2000 to 2009 and forecasts up to 2020.
- Cumulative Installed Capacities for the top five countries in the South American region from 2000 to 2009 and forecast up to 2020.
- Country wise (Brazil, Argentina, Colombia, Venezuela, Chile) cumulative and annual installed capacity for the renewable energy market from 2000 to 2009, forecast up to 2020.
- Renewable Energy wise (small hydro, wind, solar and biomass) cumulative and annual installed capacity for each of the top five countries from 2009 to 2015.
- Key topics covered include the Market Drivers, Market Restraints and Regulatory Frameworks.

Reasons to buy

The report will enhance your decision making capability in more rapid and time sensitive manner. It will allow the user to:
- Identify key growth and investment opportunities in top 5 countries in the South American Region
- Identify key entities and partners who could help in business development.
- Position yourself to gain the maximum advantage of the industry’s growth potential by developing strategies based on the latest policy and legislational events.
- Identify the drivers and restraints of 4 renewable energy markets in top 5 countries in the region.
- Facilitate decision making based on strong historic and forecast data.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/3201/South-American-Renewable-Energy-Markets-to-2020-Favorable-Policies-and-Regulations-to-Drive-Growth-in-The-Region.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Sunday, May 23rd, 2010 | Author: Vision Shopsters

Global Carbon Market is Poised for a Dramatic Growth Post 2012 under Proposed Regulations

Regulatory efforts to mitigate climate change have spawned an emerging carbon market that was valued at $10.9 billion in 2005 and grew at compound annual growth rate (CAGR) of 89% to reach $138.3 billion in 2009. The global carbon market doubled for two consecutive years form $31.2 billion in 2006 to $63 billion in 2007 and $126.3 billion in 2008 due to the expansion of allowance markets. The European Union (EU) Emission Trading System (ETS) experienced a robust growth during this period. However, the recession in the global economy contained the impressive growth of the global carbon market. The global carbon market registered a less than 1% increase in value in 2009. The primary reason for such market behavior was the sharp decline in carbon prices, on the back of lower oil and energy prices and a deteriorating economic outlook. The demand for carbon allowances fell sharply in late 2008 and early 2009 as the recession reduced economic output, resulting in much lower emissions than had been expected.

GBI Research predicts that the global carbon trading market will experience a dramatic growth after 2012 and reach $1.2 trillion by 2020. The EU’s initiatives to build a broad, globally linked carbon market, the prospective US Federal cap-and-trade program and the strong emergence of other regional market trading mechanisms will drive the carbon market significantly beyond 2012.
Primary Project Based Market is Losing Impetus Due to Uncertainty in Carbon Mitigation Mechanisms Post-2012

The primary market for project-based emission reductions declined considerably in the year 2009 under the weight of the economic downturn. The primary CDM transactions that accounted for the largest share of activity in the primary market, at 84% of volumes and 91% of value transacted, declined in both volume and value terms.

The primary market for project-based emission reductions weakened considerably in the second half of 2008 and 2009. The buyers became more cautious due to persisting uncertainty about the role of and the demand for CDM and JI in the post-2012 climate regime, procedural delays, delivery and issuance challenges, and credit risks amid the worsening economic climate.
Secondary Project-based Market: Instrument to Hedge Price Risk in the Primary Project Based Market

European traders, particularly financial and energy marketers dominated the secondary CER market. Traders hedge their exposure to price or volume risks in the primary markets through the secondary market. European Climate Exchange (ECX) data analysis indicates that traders predominantly opt for put options on guaranteed CERs, therefore hedging their price risk in the market.

The rise in trading in various exchanges and platforms by European financial and energy companies has led to a rise in the volume and value of the secondary CDM market. Hence, the trade value of secondary CDM has grown despite declining interests in project-based mechanisms. The volume transaction in the secondary market for CERs grew in 2009 to reach 1.2 billion CERs transacted for a value of $22.4 billion. Contrary to the exponential market growth in 2008, the growth of the secondary market for CERs was dampened in 2009. The marginal increase of 19% in volume transaction of CERs could not boost the market in value terms due to the decline of CER prices, which fell from $24.51 in 2008 to $17.53 in 2009. A market for options on CERs started to emerge in the second half of 2008, with hedging, profit-taking, raising cash and arbitrage as the main drivers of this market segment.
The US: Revitalized Interests in Carbon Commodity Market

Over the past years, the US has instituted a number of regional initiatives with the goals of implementing emissions trading programs. The size of the total allowance market in the US — the combined allowance volumes of the Regional Greenhouse Gas Initiative (RGGI) and the Chicago Climate Exchange – was 805 MtCO2e, valued at $2.5 billion in 2009. The US federal cap-and-trade mechanism has been expected for a long time and the implementation of the scheme will boost the North American and world carbon trading markets.

Rising investments and efforts in energy efficiency programs and renewable energy programs driving carbon trading volumes in regional markets. The RGGI states in the US – Connecticut, Delaware, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, and Vermont – have been participating in numerous clean energy projects and initiatives. RGGI states have invested in renewable energy sources and energy efficiency projects to decrease their carbon footprints. These states have created employment opportunities and generated lower electricity bill values due to their low-carbon investments. These states are investing in green building programs and are conducting workshops and training programs to improve awareness on energy efficiency measures. The clean energy initiatives have therefore boosted carbon trade in the region and the trading of carbon permits.
Hurdles in Implementation of the US Cap-and-Trade Would Affect the Dynamics of the Global Carbon Market

The US government faces hurdles in the enforcement of cap-and-trade program for GHG emissions. One of the major setbacks for the US cap-and-trade was the failure of the Copenhagen Accord to impose mandatory emission reduction targets. China, one of the largest GHG emitters, is not legally bound by the emission reduction targets and hence the existing government faces a tough challenge in the implementation of initiatives for low-carbon economy. Worldwide potential investors and eco-friendly firms are awaiting the implementation of the US cap-and-trade program as it has immense potential, and further delays in the launch of the cap-and-trade program will hinder the investments in clean energy. Prolonged delays can decelerate investments in energy efficiency and alternate energy projects. Additionally, it could lead to the postponement of the emission trading market in Canada and other carbon policy frameworks worldwide.
Sale of Recycled Carbon Credits Will Hinder Growth of the EU ETS

The EU countries are considering the sale of surrendered credits and these surrendered credits would influence the credibility of the EU ETS market. In March 2010, Hungary announced that it will sell 2 million metric tons of United Nations (UN) credits for $21m. These credits reenter the market and might be mistaken for compliance grade credits. The entry of these credits into the market would lead to lack of transparency and increase the risk of transactions. UN Certified Emission Reduction credits are on the ones generated by emission reduction projects in emerging nations and these credits can be used for compliance with GHG emission reduction targets or they can be used by power generation companies as an alternative to EU permits by governments. Hence, the Eastern European countries are using the surrendered credits in the trading markets. The International Emission Trading Association (IETA) has brought in certain initiatives to counter the resale of surrendered credits. The IETA mandates that credits surrendered to the EU registry Scannot be deployed for compliance or for carbon trading systems. The European Commission (EC) and the IETA are working together to reduce the risk of surrendered transactions and therefore improve the transparency in those transactions. There are other challenges pertaining to surrendered allowances, such as that the credits can also be sold to markets outside the EU and there is no international authority to monitor these transactions beyond the EU ETS currently.
Success in Carbon-Constrained Economy: Capture Opportunity rather than just Avoiding the Risks

Carbon substantiality is no longer compliance or a branding issue; it is now a core business issue. Global business houses and corporate across all verticals are of the view that there is a need to make carbon sustainability truly viable by practicing it in economically sustainable manner. Over the past few years, the carbon management landscape for companies has witnessed a dramatic change. The efforts to reduce carbon emissions have risen multifold and strategies to mitigate impact of climate change have reached new dimensions. Today, companies are striving to transform their compliance challenges to competitive advantage. Companies are generating business value by managing the risks and opportunities associated with climate change.

Carbon management is increasingly becoming main-stream business function due to higher awareness of the business value associated with a broader approach to carbon management. Companies are focused on generating revenue from their in-house climate change solutions and initiatives; moreover firms are identifying carbon reduction opportunities across the supply chain. Large businesses have started sharing information on their carbon performance and climate risks and opportunities with investors and other stakeholders.

GBI Research predicts that the currently climate policy and corporate carbon exposure are likely to decrease profits for corporate. Eventually, in the long run, major cost of compliance will be passed on to the consumers. Hence, early movers on climate change are likely to gain and likely to stay ahead of regulatory compliance curve. The negative carbon exposure will be in the form of compliance obligations, and this would increase the energy costs and raw material costs. Additionally, an excess cost would be incurred on implementing new technologies. Carbon trading and development of new markets may provide a silver-lining to the situation.

The success of any business in the carbon constrained economy hinges upon the ability to not only manage these risks but to also transform them into opportunities for future growth.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/3200/The-Global-Carbon-Trading-Market-Concepts-Regulations-and-Industry-Trends-to-2020.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com